Wendall Wierenga - 14 May 2025 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Reporting relationship: Director
Issuer ticker: CYTK
Reported as of: 14 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 May 2025, 19:25:35 UTC
Prior SEC filing: 21 Apr 2025
Next SEC filing: 13 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ John O. Faurescu, attorney-in-fact for Dr. Wierenga

Key filing fact

Wendall Wierenga filed Form 4 for CYTOKINETICS INC (CYTK) on 14 May 2025.

Key facts

This page summarizes Wendall Wierenga's Form 4 filing for CYTOKINETICS INC (CYTK).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 May 2025, 19:25.

Change

Previous filing in this sequence was filed on 21 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001235945 Primary reporting owner

WIERENGA WENDALL

Relationship: Director
Address: 350 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Signature: /s/ John O. Faurescu, attorney-in-fact for Dr. Wierenga
Signature date: 14 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYTK transaction

Common Stock

Award

Transaction value: $0
Shares: +7,333
Change %: +30%
Price: $0.000000
Shares after: 32,181
Date: 14 May 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYTK transaction Derivative

Non-Qualified Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +10,880
Change %
Price: $0.000000
Shares after: 10,880
Date: 14 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,880
Exercise price: $30.00
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Comprised of restricted stock units ("RSUs") that will vest in one installment on the earlier to occur of (x) the one-year anniversary of the grant date and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. RSUs convert to shares of common stock on a 1:1 basis upon vesting.

Footnote F2

Comprised of stock options that will vest monthly in equal installments over a period commencing on the grant date and ending on the earlier to occur of (x) the one-year anniversary of the date of the grant and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors.